Efficacy and Safety of Semaglutide 2.4 MG Once-Weekly in Adults With Overweight or Obesity and Type 2 Diabetes (STEP 2)

Background: In people with overweight/obesity and type 2 diabetes (T2D), achievement of weight loss can be a challenge. STEP 2 investigated the efficacy and safety of semaglutide 2.4 mg for weight management in adults with overweight/obesity and T2D. Methods: This randomized, double-blind, double-du...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Davies, Melanie, Færch, Louise, Jeppesen, Ole K, Pakseresht, Arash, Pedersen, Sue D, Perreault, Leigh, Rosenstock, Julio, Shimomura, Iichiro, Viljoen, Adie, Wadden, Thomas A, Lingvay, Ildiko
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2021
Предметы:
Adipose Tissue, Appetite, and Obesity
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089158/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.019
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы